HYPERTROPHIC CARDIOMYOPATHY (HCM)
Clinical trials for HYPERTROPHIC CARDIOMYOPATHY (HCM) explained in plain language.
Never miss a new study
Get alerted when new HYPERTROPHIC CARDIOMYOPATHY (HCM) trials appear
Sign up with your email to follow new studies for HYPERTROPHIC CARDIOMYOPATHY (HCM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart drug swap tested for safer symptom control
Disease control Recruiting nowThis study looks at whether people with a type of heart disease called obstructive hypertrophic cardiomyopathy can safely switch from one medication (mavacamten) to another (aficamten). The goal is to keep the heart working better and reduce symptoms. About 40 adults who are alre…
Matched conditions: HYPERTROPHIC CARDIOMYOPATHY (HCM)
Phase: PHASE4 • Sponsor: Oregon Health and Science University • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New scan could reveal hidden diseases
Diagnosis Recruiting nowThis study tests a new radioactive dye called 68Ga-NI-FAPI for PET/CT scans. It aims to better detect diseases like tumors, heart problems, and lung scarring by targeting a protein linked to tissue damage. About 30 people, including healthy volunteers and patients, will take part…
Matched conditions: HYPERTROPHIC CARDIOMYOPATHY (HCM)
Phase: PHASE1, PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 11:00 UTC
-
AI reads your Heart's electrical signals to spot hidden disease
Diagnosis Recruiting nowThis study uses artificial intelligence to analyze standard electrocardiograms (ECGs) to accurately diagnose hypertrophic cardiomyopathy (HCM), a condition where the heart muscle thickens. The AI will also help tell HCM apart from other diseases that look similar, like high blood…
Matched conditions: HYPERTROPHIC CARDIOMYOPATHY (HCM)
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Diagnosis
Last updated Jun 27, 2026 08:01 UTC
-
Could a simple blood thinner stop strokes before they start in heart disease patients?
Prevention Recruiting nowThis study tests whether the blood thinner rivaroxaban can prevent strokes, heart attacks, and death in people with hypertrophic cardiomyopathy (HCM) who have early signs of atrial damage but normal heart rhythm. About 532 adults aged 40-80 with HCM and reduced left atrial strain…
Matched conditions: HYPERTROPHIC CARDIOMYOPATHY (HCM)
Phase: PHASE3 • Sponsor: Rennes University Hospital • Aim: Prevention
Last updated Jun 27, 2026 13:06 UTC
-
Heart registry hopes to personalise treatment for 1-in-500 condition
Knowledge-focused Recruiting nowThis study is a national registry in the UK that collects health information from 2500 people with hypertrophic cardiomyopathy (HCM), a common inherited heart condition. Researchers will gather data from medical records, heart scans, blood tests, and genetics to better understand…
Matched conditions: HYPERTROPHIC CARDIOMYOPATHY (HCM)
Sponsor: University of Manchester • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Heart scarring over time: new study aims to predict sudden death risk in HCM patients
Knowledge-focused Recruiting nowThis study follows up on people with hypertrophic cardiomyopathy (HCM), a genetic condition that thickens the heart muscle. Researchers want to see how scarring in the heart (called late gadolinium enhancement, or LGE) changes over at least 7 years and whether it predicts serious…
Matched conditions: HYPERTROPHIC CARDIOMYOPATHY (HCM)
Sponsor: Christopher Kramer • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Heart data hunt: no treatment, but paving way for future cures
Knowledge-focused Recruiting nowThis study looks back at medical records of 100 children with a genetic condition called RASopathy that causes severe heart thickening and heart failure. Researchers want to collect detailed information on how the disease progressed in the past. This will help design future studi…
Matched conditions: HYPERTROPHIC CARDIOMYOPATHY (HCM)
Sponsor: Deutsches Herzzentrum Muenchen • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
Heart tissue analysis aims to unlock better diagnosis
Knowledge-focused Recruiting nowThis study looks at heart tissue samples from 216 adults who already need a biopsy as part of their care. Researchers want to find unique molecular patterns in different heart conditions, including after a heart transplant. The goal is to improve how these diseases are diagnosed …
Matched conditions: HYPERTROPHIC CARDIOMYOPATHY (HCM)
Sponsor: University Hospital, Essen • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
New heart MRI study could simplify diagnosis without dye
Knowledge-focused Recruiting nowThis study will use cardiac MRI scans to measure heart tissue in 2000 people with various heart conditions, such as heart attacks, cardiomyopathies, and myocarditis. The goal is to create a reference map of normal and abnormal tissue values, which may help doctors diagnose diseas…
Matched conditions: HYPERTROPHIC CARDIOMYOPATHY (HCM)
Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC